Evidence map›Paper›PMID 36768744›Full record

ReviewInternational journal of molecular sciences2023

Hypoxia and Intestinal Inflammation: Common Molecular Mechanisms and Signaling Pathways.

Kristina A Dvornikova, Olga N Platonova, Elena Y Bystrova

Registry-linked trialAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07621367 (Efficacy and Safety of Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07621367 narecruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Gut Oxygen Therapy for Ischemic-Hypoxic Bowel Disease: A Single-center, Double-blind, Randomized, Intra-individual Crossover Controlled Study

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2026 to 2031Enrolled100ConditionsChronic Ischemic-Hypoxic EnteropathyArmsOxygen (O2) -Sham group, Sham -Oxygen (O2) group
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. International journal of chronic obstructive pulmonary disease · 2026
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Pharmacological Activation of TRPC6 Channel Prevents Colitis Progression.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kristina A DvornikovaI.P. Pavlov Institute of Physiology RAS, 199034 St. Petersburg, Russia.ORCID 0000-0002-1372-9824
Olga N PlatonovaI.P. Pavlov Institute of Physiology RAS, 199034 St. Petersburg, Russia.ORCID 0000-0002-4845-2511
Elena Y BystrovaI.P. Pavlov Institute of Physiology RAS, 199034 St. Petersburg, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gastrointestinal tract (GI) has a unique oxygenation profile. It should be noted that the state of hypoxia can be characteristic of both normal and pathological conditions. Hypoxia-inducible factors (HIF) play a key role in mediating the response to hypoxia, and they are tightly regulated by a group of enzymes called HIF prolyl hydroxylases (PHD). In this review, we discuss the involvement of inflammation hypoxia and signaling pathways in the pathogenesis of inflammatory bowel disease (IBD) and elaborate in detail on the role of HIF in multiple immune reactions during intestinal inflammation. We emphasize the critical influence of tissue microenvironment and highlight the existence of overlapping functions and immune responses mediated by the same molecular mechanisms. Finally, we also provide an update on the development of corresponding therapeutic approaches that would be useful for treatment or prophylaxis of inflammatory bowel disease.

Indexed as

Inflammatory Bowel DiseasesIntestinal MucosaHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitInflammationSignal TransductionHypoxia-Inducible Factor 1, alpha Subunitadaptive immunityCrohn’s diseaseHIF-1αHIF-2αhypoxiainflammationinflammatory bowel diseaseinnate immunityulcerative colitis

Identifiers

PMID36768744
PMCPMC9917195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.